Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001393825-24-000047
Filing Date
2024-02-05
Accepted
2024-02-05 17:09:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 ENVB 13GA envb_13ga.htm SC 13G/A 53956
2 GRAPHIC image_002.gif GRAPHIC 89
  Complete submission text file 0001393825-24-000047.txt   56123
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Subject) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-53543 | Film No.: 24596725
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 28 HAVEMEYER PLACE 2ND FLOOR GREENWICH CT 06830
Business Address 28 HAVEMEYER PLACE 2ND FLOOR GREENWICH CT 06830 203-718-5690
Hudson Bay Capital Management LP (Filed by) CIK: 0001393825 (see all company filings)

EIN.: 371511173 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A